These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32191819)

  • 21. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Goh NS; McDonald CE; MacGregor DP; Pretto JJ; Brodie GN
    Respirology; 2003 Mar; 8(1):91-4. PubMed ID: 12856748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
    Kornblau SM; Gandhi V; Andreeff HM; Beran M; Kantarjian HM; Koller CA; O'Brien S; Plunkett W; Estey E
    Leukemia; 1996 Oct; 10(10):1563-9. PubMed ID: 8847890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
    Ottaviano F; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis.
    Saven A; Foon KA; Piro LD
    Ann Intern Med; 1994 Sep; 121(6):430-2. PubMed ID: 7914398
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.
    Pagano L; Criscuolo M; Broccoli A; Piciocchi A; Varettoni M; Galli E; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Frustaci A; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Offidani M; Casadei B; Nizzoli ME; De Luca ML; Fianchi L; Motta M; Guarnera L; Simonetti E; Visentin A; Vassallo F; Deodato M; Sarlo C; Olivieri A; Falini B; Pulsoni A; Tiacci E; Zinzani PL
    Blood Cancer J; 2022 Jul; 12(7):109. PubMed ID: 35853850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract.
    Mayumi A; Imamura T; Sakamoto K; Ota T; Osone S; Usami I; Hosoi H
    Int J Hematol; 2019 Dec; 110(6):756-762. PubMed ID: 31350665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug therapy for the treatment of Langerhans cell histiocytosis.
    McClain KL
    Expert Opin Pharmacother; 2005 Nov; 6(14):2435-41. PubMed ID: 16259575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.
    Weitzman S; Wayne AS; Arceci R; Lipton JM; Whitlock JA
    Med Pediatr Oncol; 1999 Nov; 33(5):476-81. PubMed ID: 10531572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
    Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
    Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W
    Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
    Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk organ + LCH gets the one-two punch?
    Stine KC
    Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Langerhans cell histiocytosis: old disease new treatment.
    Ng-Cheng-Hin B; O'Hanlon-Brown C; Alifrangis C; Waxman J
    QJM; 2011 Feb; 104(2):89-96. PubMed ID: 21084318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases.
    Esmaili N; Harris GJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):28-34. PubMed ID: 25689784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Langerhans cell histiocytosis, a case of Letterer Siwe disease.
    Pant C; Madonia P; Bahna SL; Bass PF; Jeroudi M
    J La State Med Soc; 2009; 161(4):211-2. PubMed ID: 19785312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
    Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
    Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.